Abstract:Cryptotanshinone is a natural abietane type-diterpene quinine isolated from the lipophilic extract of Tanshen (or Danshen, Salvia miltiorrhiza Bunge) which is widely used in clinical applications for treating inflammations such as acne, tonsillitis and mastitis at present. Previous studies indicated that cryptotanshinone could not only inhibit the growth of androgen dependent and castration resistant prostate cancer cells by suppressing the androgen receptor (AR), but also inhibit estrogen receptor (ER)-positive breast cancer cell proliferation by suppressing ER signals. In this work, we found cryptotanshinone can effectively inhibit the proliferation of ER-negative breast cancer Bcap37 cells. Cryptotanshinone induced mitochondria-mediated apoptosis through changes in nuclear morphology, DNA fragmentation, loss of mitochondrial membrane potential, activation of caspase-like activities and translocation of endonuclease G (EndoG) from mitochondria into nucleus. During the process, the caspases inhibitor could not completely abrogate apoptosis caused by cryptotanshinone, suggesting that the intrinsic caspase-independent signaling functioned was one of the major pathways under high stress of cryptotanshinone. In addition, the apoptosis involved several key signals of cell proliferation and ROS regulation, such as suppression of PTEN and up-regulation of phosphorylated-AKT (Ser 473), thus the expression of a key transcription factor FOXO1 was down-regulated further and resulted in accumulation of ROS that brought about the following oxidative DNA damage. In summary, the results showed that cryptotanshinone might be a promising apoptosis-inducing agent in the treatment of ER-negative breast cancers by activation of mitochondria-derived ROS/FOXO1 signaling pathways.

Supplementary Figures 1-3 from Cryptotanshinone Inhibits Cancer Cell Proliferation by Suppressing Mammalian Target of Rapamycin–Mediated Cyclin D1 Expression and Rb Phosphorylation

Cryptotanshinone, a Novel Tumor Angiogenesis Inhibitor, Destabilizes Tumor Necrosis Factor‐α Mrna Via Decreasing Nuclear–cytoplasmic Translocation of RNA‐binding Protein HuR

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Data from Cryptotanshinone Inhibits Cancer Cell Proliferation by Suppressing Mammalian Target of Rapamycin–Mediated Cyclin D1 Expression and Rb Phosphorylation

Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Cryptotanshinone inhibits proliferation and induces apoptosis via mitochondria-derived reactive oxygen species involving FOXO1 in estrogen receptor-negative breast cancer Bcap37 cells

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Cryptotanshinone Inhibits Proliferation Yet Induces Apoptosis by Suppressing STAT3 Signals in Renal Cell Carcinoma.

Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacity

Supplementary Figure 2 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Supplementary Figure 1 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Supplemental Materials and Methods and Supplemental Figure Legends from Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells

Legend for Supplementary Figures from Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma

Supplementary Figures 1-4 from Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Cryptotanshinone suppresses the proliferation and induces the apoptosis of pancreatic cancer cells via the STAT3 signaling pathway.

Supplementary Figures 1-2 from Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3

Supplementary Figures 1-6, Tables 1-15, Methods from Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Supplementary Data from Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway

Cryptotanshinone induces G1 cell cycle arrest and autophagic cell death by activating the AMP-activated protein kinase signal pathway in HepG2 hepatoma

Supplementary Figures 1-5 from Caveolin-1 Upregulation Mediates Suppression of Primary Breast Tumor Growth and Brain Metastases by Stat3 Inhibition